U.S. markets closed

S&P Futures
4,407.50
-6.75(-0.15%)
Dow Futures
34,978.00
-56.00(-0.16%)
Nasdaq Futures
15,097.50
-20.25(-0.13%)
Russell 2000 Futures
2,208.90
-4.50(-0.20%)
Crude Oil
72.20
+0.29(+0.40%)
Gold
1,797.90
-1.30(-0.07%)

Vapotherm, Inc. (VAPO)

NYSE - NYSE Delayed Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

23.58+0.04 (+0.17%)

At close: 4:00PM EDT

23.58 -0.03 (-0.13%)
After hours: 04:01PM EDT

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Triple Moving Average Crossover

View all chart patterns

Performance Outlook

Previous Close	23.54
Open	23.65
Bid	18.74 x 1100
Ask	25.71 x 900
Day's Range	22.67 - 23.77
52 Week Range	16.64 - 54.42
Volume	304,390
Avg. Volume	224,587

Market Cap	610.996M
Beta (5Y Monthly)	-1.60
PE Ratio (TTM)	N/A
EPS (TTM)	-1.92
Earnings Date	May 05, 2021
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	40.00

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

All

News

Press Releases

Research Reports

Business Wire
Vapotherm to Report Second Quarter 2021 Financial Results
EXETER, N.H., July 21, 2021--Vapotherm, Inc. (NYSE: VAPO) ("Vapotherm" or the "Company"), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products which are used to treat patients of all ages suffering from respiratory distress, today announced that it will release financial results for the second quarter of 2021 after the close of trading on Monday, August 9, 2021. Vapotherm’s management team will host a co
- Cinemark to Host Second Quarter 2021 Earnings Conference Call
  Business Wire
- Chuy’s Holdings, Inc. to Announce Second Quarter 2021 Results on August 5, 2021
  GlobeNewswire
TipRanks
Vapotherm Could Provide a Breath of Fresh Air to Investors
Vapotherm Inc. (VAPO) is a medical technology company that primarily focuses on developing and monetizing its Hi-VNI technology. It leverages its proprietary Precision Flow system via four different versions (Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox) to treat respiratory distress. Conditions it treats include pneumonia, COPD, heart failure, and asthma. The main value for VAPO comes from the sale of its proprietary Precision Flow systems to hos
Simply Wall St.
Is Vapotherm (NYSE:VAPO) Weighed On By Its Debt Load?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...